DUBAI, United Arab Emirates, March 02, 2023 (GLOBE NEWSWIRE) -- The global dry eye syndrome treatment market is anticipated to exceed a value of US$ 8.84 billion by 2032, with sales growing at a positive CAGR of 7.0% from 2022 to 2032. Historically, the market rose from a value of US$ 4.52 billion in 2021 and reached US$ 4.80 billion by 2022. Increasing incidences of dry eye syndrome coupled with the high demand for effective dry eye treatment for relieving different symptoms are key factors that fuel the growth of the dry eye syndrome treatment market during the assessment period. Recent developments like greater research and development efforts in this field including new product releases such as the estimated launch of NOV03- which met all clinical endpoints in September of 2021- in 2023 will also contribute to the expansion of the dry eye syndrome treatment market.
Dry eye syndrome treatment includes different varieties of therapeutics that are used to treat the syndrome. These therapeutics substantially lessen the different symptoms related to dry eye syndrome and thereby enhance the quality of life of the patients. Historically, the market for dry eye syndrome treatment registered an annual growth rate of 6.2% from 2016 to 2021 and reached US$ 4.52 billion in 2021. The forecasted growth for the market can be attributed to factors such as the rising prevalence of dry eye all over the world, an upsurge in product innovation and development, a spike in the number of LASIK surgeries, and swift development of the eyedrop market. The growing geriatric population worldwide also serves as a prime driver for the market as eyes release fewer tears in the elderly resulting in greater evaporation and dryness.
Request Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1215
In recent years, elevated usage of contact lenses often leads to dryness in the eyes which encourages higher adoption rates of products that will ensure good health for the eyes. Additionally, the increasing awareness among the general population regarding dry eye syndrome and its symptoms will likely bolster market sales. The rapid growth of the eye infections treatment market across developing regions will also foster an environment of growth for the dry eye syndrome treatment market. The expansion of the dry eye remedies market in emerging economies and the heightened adoption of eyedrops by patients to relieve various symptoms will open avenues of growth for manufacturers of the dry eye syndrome treatment market.
In spite of the projected positive outlook, the dry eye syndrome treatment market will face its share of hardships. The stringent regulations regarding the drugs available for treatment and long-term treatment regimens will impede the market growth. A general lack of awareness of eye issues and a dearth of certain products in emerging economies will also restrict the growth of the dry eye syndrome treatment market.
Key Takeaways:
- The US accounted for 80.6% of the North American dry eye syndrome treatment market in 2022.
- In 2022, Germany held about 17.2% of the dry eye syndrome treatment market share in Europe.
- Based on the product type, the artificial tears category will expand at a 7.1% CAGR.
- By distribution channel, the hospital pharmacies will continue to dominate the market in the assessment period.
View Complete Report@ https://www.futuremarketinsights.com/reports/dry-eye-syndrome-treatment-market
Competitive Landscape
In a competitive environment, prominent market players are focusing on increasing research and development efforts to develop new products with long-lasting attributes and greater efficiency. These organizations vigorously engage in product launches, agreements, and approvals to enhance their market footprints. In the recent timeline, that is between 2019 and 2021, many businesses have actively sought product approval and concentrated on releasing novel products. For instance, in October 2021, Tyrvaya nasal spray for dry eye was approved by the US Food and Drug Administration (FDA). Other developments include the October 2019 announcement of Sun Pharmaceutical Industries Ltd., that one of its subsidiaries had commercialized CEQUA (cyclosporine ophthalmic solution) 0.09% in the US.
Novartis AG, Otsuka Pharmaceuticals Co, Ltd., Bausch Health Companies, and Johnson & Johnson, Inc., among others, are a few of the other key players in the dry eye syndrome treatment market profiled in the full version of the report.
More Insights into Dry Eye Syndrome Treatment Market
For a comprehensive understanding of the global market potential, growth, and scope, the market is segmented on the basis of product type, prescription, distribution channel, and region. According to the same reports, based on segmentation, the Rx (prescription) medicine category held about 71.4% of the overall market share in 2021. In terms of distribution channels, the retail and hospital pharmacies segment will lead the market growth. Based on region, the dry eye syndrome treatment market in the US, Germany, and China will present impressive growth during the forecast period.
In this latest report, FMI offers a detailed and unbiased analysis of the global dry eye syndrome treatment market, providing historical data from 2016 to 2021 and forecast statistics for 2022 to 2032. The report highlights include a 9-year realistic sales prediction for the market, demand and supply trend analysis, illustrative representation of statistical data, and strategies adopted by leading players to retain a competitive edge.
Dry Eye Syndrome Treatment Market By Category
By Product:
- Cyclosporine
- Topical Corticosteroids
- Artificial Tears
- Punctal Plugs
- Removable
- Dissolvable
- Oral Omega Supplements
- Others
By Prescription:
- Rx
- OTC
- Medical Device
By Distribution Channel:
- Hospital Pharmacies
- Eye Health Clinics
- Retail Pharmacies
- Online Pharmacies
Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-1215
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusion and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Method Innovation / Development Trends
4. Key Success Factors
4.1. Dry Eye Syndrome Epidemiology, By Country, 2016-2031
4.1.1. Prevalence of dry eye disease
4.1.2. Potential patient number of dry eye disease
4.1.3. Percentage of severity, mild, modulate, and severe
4.1.4. Patients number under treatment
4.1.5. Prevalence of MGD and occurrence rate of dry eye among MGD patient
4.2. Regulatory Scenario
4.3. New Product Launches
4.4. Reimbursement Scenario
4.5. Dry Eye Syndrome- Diagnostics protocol/ Criteria by key countries
4.6. Dry Eye Syndrome – Patient Treatment Journey
Buy Now@ https://www.futuremarketinsights.com/checkout/1215
Have a Look at Related Reports of Healthcare domain
Myelodysplastic Syndrome Treatment Market Size: The global myelodysplastic syndrome treatment market is poised to register a 5.9% CAGR, capturing a revenue share of US$ 2,990.8 million in 2022, to reach US$ 5,614.1 million by 2032.
NGS Sample Preparation Market Share: The global NGS sample preparation market worth is expected to rise at a CAGR of 13.7% to US$ 5.4 Billion by 2032.
New Born Eye Imaging Systems Market Demand: The global new born eye imaging systems market is forecasted to be valued at US$ 374.3 million by 2032, up from US$ 202.7 million in 2022, advancing at a CAGR of 5.7% during the forecast period.
Neuronavigation Systems Market Overview: The global neuronavigation systems market is forecasted to be appraised at US$ 4794.5 million by 2032, up from US$ 2120.0 million in 2022, advancing at a CAGR of 7.7% during the forecast period.
Next Generation Infusion Pump Market Outlook: The global next generation infusion pump market holds a forecasted share of US$ 5059.7 million in 2022 and is likely to surpass US$ 8509 million by 2032, moving ahead with a CAGR of 4.8% during the forecast period
About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai and has delivery centers in the UK, US, and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Contact Us:
Future Market Insights, Inc.
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
LinkedIn| Twitter| Blogs | YouTube
For Sales Enquiries: sales@futuremarketinsights.com
